Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22792,95,0.84 [0.45-1.57],0.5842040649570107
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23405,175,1.16 [0.83-1.62],0.3877533374515578
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23175,1132,1.11 [0.97-1.28],0.1297604418249973
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Candidiasis,23426,396,1.23 [1.00-1.51],0.0519915111389396
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22703,2958,1.12 [1.02-1.21],0.0116402980953301
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22907,2419,1.19 [1.09-1.31],0.0001871109016935
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23193,1152,1.11 [0.97-1.27],0.114627024706615
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23337,78,1.39 [0.93-2.07],0.1039061222490922
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21877,675,1.32 [1.14-1.54],0.0002662119511447
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21152,783,1.24 [1.06-1.45],0.0077302810814642
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,21194,213,1.19 [0.87-1.62],0.2755145213798661
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16425,1390,1.13 [1.00-1.28],0.0443028136872861
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20993,308,1.26 [0.98-1.62],0.0682145168823599
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23378,1337,1.13 [1.00-1.28],0.050853600163309
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Mycoses,23479,449,1.22 [1.01-1.49],0.0428342164178353
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22841,798,1.22 [1.05-1.42],0.009309771116105
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23437,740,1.27 [1.09-1.47],0.001576283666601
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22216,175,1.17 [0.84-1.62],0.3582538508256304
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23538,38,1.09 [0.50-2.40],0.8291806684241287
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23354,657,1.32 [1.14-1.53],0.0002178256862163
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23333,74,1.07 [0.62-1.86],0.8058043973499771
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23453,164,1.17 [0.84-1.62],0.3667341136475779
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23439,150,1.08 [0.74-1.58],0.6858910130596348
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22339,296,1.18 [0.91-1.52],0.212054311886159
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22263,220,0.83 [0.55-1.25],0.3756445420162182
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22140,99,1.21 [0.77-1.88],0.4053465055972532
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23516,33,1.38 [0.74-2.58],0.3059604155858905
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23470,139,1.06 [0.71-1.58],0.7752929257421672
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Viral warts,23372,41,0.59 [0.19-1.78],0.3471828118898391
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23400,69,1.11 [0.64-1.91],0.7119374273323171
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign lipomatous neoplasm,23295,201,0.90 [0.60-1.33],0.5828523105375503
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23449,58,0.68 [0.29-1.62],0.3836904098532755
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23438,59,1.25 [0.75-2.09],0.397979181041233
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23284,1037,0.80 [0.67-0.97],0.0211378888297951
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm of meninges,23514,73,1.77 [1.37-2.27],9.293778621980622e-06
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23479,59,1.36 [0.87-2.13],0.1770599390347756
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23506,114,0.73 [0.40-1.35],0.3232902191528079
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm of ovary,23467,147,0.66 [0.38-1.14],0.139324480774117
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23518,236,0.88 [0.60-1.27],0.4881686316893446
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Caecum,23524,214,0.95 [0.66-1.37],0.7835109222285511
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23458,58,0.74 [0.32-1.72],0.4898427123826723
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Descending colon,23522,131,0.87 [0.53-1.44],0.5987526011957534
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Rectum,23483,238,0.68 [0.44-1.04],0.0784941610598094
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23440,433,0.92 [0.71-1.19],0.5343850714890495
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23523,246,0.78 [0.52-1.15],0.2105631506665642
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Carcinoma in situ of breast,19054,117,1.05 [0.69-1.60],0.8156692163633772
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19124,135,0.98 [0.64-1.50],0.9250710576821995
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",19118,29,1.01 [0.40-2.51],0.9887930840942264
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",19144,55,1.53 [1.01-2.31],0.0433497636755148
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23479,120,1.29 [0.92-1.80],0.1404332587371235
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Haemangioma, any site",23480,118,1.23 [0.86-1.77],0.2535508888472747
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Leiomyoma of uterus,22684,489,1.04 [0.84-1.29],0.7040514728354772
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Lung cancer and mesothelioma,16888,280,0.94 [0.66-1.34],0.743378778205604
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Lymphoid leukaemia,19121,32,1.14 [0.53-2.45],0.7432434545242513
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19241,152,1.05 [0.73-1.52],0.7808978888015364
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",19188,99,1.57 [1.20-2.06],0.0010513866858416
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19252,163,1.07 [0.73-1.56],0.7396200651119245
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",19152,63,0.94 [0.48-1.85],0.8646738144185497
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",19152,63,1.32 [0.82-2.14],0.2549261788115948
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",19137,48,1.30 [0.74-2.29],0.3583782703976765
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19218,129,0.96 [0.61-1.52],0.8597832141021297
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",19179,90,0.80 [0.41-1.53],0.4972163616551391
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",19160,71,1.05 [0.60-1.84],0.8709415516957246
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",19124,35,1.65 [1.07-2.56],0.0242759072300713
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,19160,71,0.77 [0.37-1.59],0.4733551588695945
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Melanocytic naevi,23306,205,1.09 [0.81-1.48],0.5636261245426977
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Melanocytic naevi of trunk,23498,68,0.74 [0.35-1.55],0.4246139004251564
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Melanoma in situ,19117,75,1.14 [0.69-1.88],0.6028610525761082
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",19159,70,1.52 [1.06-2.18],0.022635563413232
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19221,132,1.50 [1.16-1.95],0.0021570726291785
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",19294,205,0.80 [0.52-1.24],0.3155000663642812
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",19171,82,1.53 [1.12-2.09],0.0082436819990645
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Other benign neoplasms of skin,23344,153,0.86 [0.55-1.36],0.5274514715050411
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19874,785,0.98 [0.82-1.17],0.8399216319508394
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19910,821,0.96 [0.80-1.15],0.6400021008911163
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23261,336,1.18 [0.94-1.48],0.146355723247426
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21843,82,1.47 [1.02-2.11],0.0381261468624652
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22995,70,1.11 [0.64-1.91],0.7115146542781571
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22669,2526,1.14 [1.04-1.25],0.0043676802647511
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22158,27,1.34 [0.63-2.82],0.4482372888268107
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23191,45,1.64 [1.12-2.42],0.0117595466911988
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23041,1280,1.14 [1.01-1.30],0.0348583658154862
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23041,1280,1.14 [1.01-1.30],0.0348583658154862
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21825,64,1.08 [0.60-1.95],0.7870507351135395
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23190,1059,1.19 [1.04-1.36],0.0094727371773596
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23248,102,1.10 [0.70-1.73],0.6832364417140613
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22967,42,0.91 [0.38-2.19],0.8377094618293612
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22978,53,0.78 [0.33-1.84],0.5711417151207454
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23352,206,1.41 [1.12-1.77],0.0033044715705986
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23445,50,1.00 [0.49-2.02],0.9989499085571666
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23321,175,1.41 [1.10-1.80],0.006190907485986
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22239,108,1.16 [0.76-1.75],0.4944763503336695
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,18974,206,1.17 [0.85-1.61],0.3325768627698801
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22311,60,1.28 [0.84-1.95],0.2517184412984753
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22305,54,1.25 [0.62-2.52],0.5262684199059355
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,18810,42,1.41 [0.83-2.39],0.1995340168357916
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21586,54,1.53 [0.99-2.35],0.0537479526641664
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21292,203,1.15 [0.83-1.59],0.3908622587154085
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23165,414,1.22 [0.99-1.52],0.068314088402055
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23008,257,1.01 [0.73-1.39],0.9751397625023824
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22808,57,1.11 [0.60-2.07],0.7375969586680519
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23210,1678,1.04 [0.92-1.17],0.5527951662944951
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,20873,1640,1.04 [0.93-1.18],0.4803862272545187
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",18813,45,0.91 [0.40-2.10],0.825912929401841
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",20913,101,0.78 [0.41-1.46],0.4335937199692455
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,19015,247,1.18 [0.89-1.56],0.2585254884325052
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,18811,43,0.67 [0.24-1.83],0.4308930483301075
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21462,2694,1.00 [0.91-1.11],0.9714359182147873
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,18950,182,1.19 [0.86-1.64],0.2911235294672777
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,19242,474,1.09 [0.88-1.36],0.4123389593144643
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23451,310,1.28 [1.03-1.60],0.0284250673341695
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23287,146,1.30 [0.94-1.79],0.1084033225052785
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,18854,86,0.94 [0.53-1.68],0.8397192484866809
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",18817,49,1.01 [0.49-2.08],0.9874244768019445
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22788,1976,1.09 [0.98-1.21],0.1156410812344309
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,18937,169,1.19 [0.83-1.69],0.339849866653655
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,18937,169,1.42 [1.08-1.87],0.01312784992292
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19224,456,0.99 [0.77-1.27],0.9240771403557104
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,18836,68,0.97 [0.50-1.88],0.9195115756870124
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23281,140,1.05 [0.69-1.60],0.8296589703027764
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,19291,523,1.15 [0.95-1.40],0.1491218205295373
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,19243,475,1.07 [0.85-1.33],0.564849741749319
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21148,59,1.40 [0.89-2.21],0.1499682700223198
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22784,4016,1.06 [0.98-1.15],0.1367289286455209
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,20875,63,0.99 [0.51-1.92],0.9653046907444164
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,20888,76,0.96 [0.52-1.75],0.8822148399741742
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23374,1762,0.98 [0.86-1.12],0.8050671657702986
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23378,1761,0.98 [0.86-1.12],0.7910157719251936
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,20884,72,0.66 [0.29-1.49],0.3212715176996266
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23184,1354,1.05 [0.92-1.19],0.4869036855026039
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20041,1273,1.17 [1.04-1.33],0.0123632457422146
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23528,153,1.23 [0.86-1.77],0.2549109877601706
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22791,40,1.53 [0.91-2.57],0.1076937766245497
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,21945,115,1.15 [0.76-1.73],0.5071155129143349
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,21998,168,0.86 [0.55-1.35],0.5221328790908052
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",18981,213,1.33 [1.05-1.70],0.0204931764068724
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,21979,120,1.27 [0.87-1.86],0.2146040068446589
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1453,37,1.24 [0.61-2.49],0.5527463220307617
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1548,150,1.24 [0.88-1.76],0.2220720426154032
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,21882,23,0.96 [0.28-3.30],0.942817326222426
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1437,22,0.87 [0.20-3.73],0.8555145528052568
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23132,1273,1.10 [0.96-1.27],0.1719772568045496
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23028,277,1.13 [0.85-1.51],0.3945365853585116
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21505,416,1.06 [0.83-1.35],0.6623820373101683
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19375,607,1.11 [0.91-1.34],0.3048728345519779
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23450,202,1.03 [0.72-1.47],0.8666640032913197
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22652,44,1.06 [0.49-2.29],0.8833262423736464
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Angina pectoris,22227,742,1.04 [0.87-1.25],0.6539167470334717
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22687,79,0.91 [0.48-1.73],0.7795251501352571
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22636,28,0.68 [0.18-2.57],0.5729009241639544
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22744,136,1.13 [0.75-1.71],0.5502781758171473
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,15288,1246,1.13 [0.98-1.29],0.0831669189825976
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,AV-block,20642,208,0.85 [0.56-1.29],0.4420637617139134
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23497,258,1.03 [0.75-1.40],0.8614226092360551
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Cardiac arrest,14148,106,1.29 [0.85-1.94],0.2299309040408225
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Cardiomyopathy,20553,119,1.21 [0.82-1.78],0.3476113825773937
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",20505,71,1.05 [0.58-1.87],0.8813533067183664
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23535,28,1.34 [0.68-2.64],0.3958505946375553
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Conduction disorders,21051,617,1.04 [0.85-1.28],0.6879250974910118
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22755,1281,1.06 [0.92-1.21],0.4427001513159504
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21183,6246,1.02 [0.96-1.09],0.4925670623456387
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22257,214,0.98 [0.69-1.41],0.9318172460943324
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Endocarditis,20482,48,1.65 [1.12-2.42],0.0110023328618056
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23455,709,1.29 [1.10-1.51],0.0013994358131615
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Hypertension,21721,5246,1.00 [0.94-1.08],0.9000357820958823
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21730,5255,1.00 [0.93-1.08],0.9019518384064164
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23437,34,1.17 [0.53-2.56],0.701075247792297
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16628,153,1.39 [1.01-1.91],0.0413583616337415
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16538,63,1.51 [0.97-2.35],0.0668647593914031
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Hypotension,23425,909,1.05 [0.90-1.24],0.5221631000278428
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22900,84,1.40 [0.95-2.06],0.0855299527681684
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22929,1444,1.02 [0.89-1.17],0.7431528695940056
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23269,379,1.19 [0.95-1.49],0.1295676120630904
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Left bundle-branch block,20694,260,1.17 [0.89-1.55],0.2586798792688326
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23352,521,1.04 [0.83-1.30],0.7220848809603861
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",21902,417,1.02 [0.80-1.31],0.8602606894154626
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23515,74,1.12 [0.65-1.92],0.6914806929674777
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23530,205,1.02 [0.71-1.46],0.9182858275868584
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Oesophageal varices,22076,33,1.30 [0.66-2.54],0.4463009190299135
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other aneurysm,22655,47,1.09 [0.57-2.10],0.7935286906072132
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other arrhythmias,20750,316,1.21 [0.96-1.53],0.1041345554181243
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22667,59,0.96 [0.47-1.99],0.9162647321060656
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22779,171,1.04 [0.71-1.53],0.8308542399274264
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,20580,146,0.93 [0.59-1.47],0.7686632635864206
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other disorders of veins,22117,74,1.23 [0.75-2.02],0.4023872711546019
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22085,42,0.60 [0.20-1.78],0.356058497956341
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22478,31,1.14 [0.51-2.57],0.7488233980900332
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22174,131,1.01 [0.64-1.60],0.9567297028837072
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21104,670,1.25 [1.06-1.47],0.0091400725750414
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22551,35,0.47 [0.13-1.74],0.2583297257658638
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23052,444,1.03 [0.81-1.31],0.7982251393979185
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23040,284,1.21 [0.93-1.58],0.1598341275838123
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22900,453,1.12 [0.90-1.41],0.3115451847050061
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14292,250,1.26 [0.98-1.63],0.0678727268304345
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22839,241,0.98 [0.69-1.39],0.9096127737246572
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22324,281,1.06 [0.79-1.42],0.7005685885019102
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23132,376,1.10 [0.86-1.41],0.4263165727986252
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23468,496,1.15 [0.94-1.42],0.1678126311917736
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Right bundle-branch block,20617,183,0.94 [0.63-1.41],0.7652158424836726
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23033,277,1.23 [0.94-1.60],0.1313480968803881
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22578,131,1.46 [1.09-1.97],0.0115246517457944
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23260,444,1.21 [0.99-1.48],0.0665218788762985
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23238,484,1.19 [0.98-1.45],0.0848074414114746
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22873,62,1.16 [0.66-2.04],0.5941237405230075
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,22642,34,1.03 [0.45-2.35],0.951061486444289
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23071,181,0.76 [0.48-1.22],0.2576304981321684
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23004,173,1.02 [0.68-1.52],0.9264281413694092
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Varicose veins,22420,377,1.13 [0.90-1.43],0.2879069130711607
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,22616,80,0.98 [0.54-1.78],0.942720593934919
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23352,596,1.09 [0.89-1.32],0.3952812848717834
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23500,195,0.96 [0.66-1.40],0.8430363162486118
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20922,1582,1.03 [0.91-1.16],0.652777813526605
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Any mental disorder,23029,3689,1.05 [0.97-1.14],0.1989306518236056
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23475,233,1.16 [0.88-1.54],0.2844165654116619
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21035,1695,1.06 [0.94-1.19],0.3469419902097457
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19418,78,1.29 [0.83-2.00],0.2571273423271975
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Smoking dependency,23188,1022,1.04 [0.88-1.24],0.6364320478788918
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20528,1188,1.08 [0.94-1.23],0.285787648670864
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Vascular dementia,23126,91,0.99 [0.56-1.74],0.969976789505963
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Alzheimer disease,23537,317,0.95 [0.70-1.29],0.7233921062165576
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",16128,53,0.54 [0.19-1.56],0.2572680698803063
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Bell's palsy,21692,69,1.31 [0.84-2.03],0.2326439028487943
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22172,549,0.74 [0.57-0.97],0.0313363445235115
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Cerebral cysts,23195,188,1.17 [0.86-1.59],0.3078351415148367
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23475,235,1.28 [0.98-1.67],0.0661939088177063
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23122,36,0.88 [0.34-2.28],0.7980350936029028
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23525,43,1.20 [0.64-2.24],0.5667612267245723
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23051,44,1.29 [0.73-2.27],0.3822829627030788
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Epilepsy,22285,241,0.96 [0.69-1.34],0.828522388225533
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23172,1128,0.96 [0.82-1.12],0.6024903219921731
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23492,307,0.92 [0.67-1.26],0.5903209040415278
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22996,2473,1.06 [0.96-1.17],0.2221829128828101
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Generalized epilepsy,23221,41,0.84 [0.33-2.11],0.7063303238092382
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Hemiplegia,23425,185,1.37 [1.04-1.80],0.0258636070346393
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Hydrocephalus,23061,54,0.97 [0.47-2.00],0.9239701512889322
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23518,66,0.91 [0.46-1.78],0.7837050509331417
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21732,109,0.81 [0.47-1.42],0.4706423835707558
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21678,55,0.37 [0.12-1.13],0.0798774446989506
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Memory loss,23013,89,0.87 [0.47-1.60],0.6484321985421433
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Migraine,22478,434,0.88 [0.68-1.15],0.3478452707301526
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23437,395,0.83 [0.62-1.11],0.2182715218998932
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Motor neuron disease,16210,111,0.71 [0.38-1.32],0.279049119865139
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23341,124,0.96 [0.61-1.52],0.8698531794105147
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22821,1198,0.94 [0.80-1.09],0.4102510909912512
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Neurological diseases,22149,3170,1.00 [0.91-1.09],0.985689860441766
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23207,121,0.89 [0.53-1.51],0.6688865599433418
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21987,364,0.90 [0.67-1.20],0.4690467125833583
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23487,192,1.16 [0.84-1.60],0.3621590682113538
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19044,568,0.94 [0.75-1.19],0.6220955289235582
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23064,57,1.01 [0.51-1.99],0.9749414218692828
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23116,109,1.23 [0.82-1.84],0.3116531087558953
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23327,142,0.95 [0.61-1.48],0.8169401325896006
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21700,77,1.19 [0.74-1.90],0.4737712156393989
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other headache syndromes,22110,66,1.08 [0.60-1.94],0.7987712228678902
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other neurological diseases,23438,431,1.23 [1.01-1.50],0.0364010234140446
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other sleep disorders,22383,339,1.14 [0.89-1.46],0.2950219159677817
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Parkinson's disease,23513,145,0.81 [0.49-1.34],0.4222003330925342
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23080,73,1.18 [0.75-1.86],0.4705530573370802
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Restless leg syndrome,23535,76,1.13 [0.68-1.89],0.6406531650531966
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Sleep apnoea,23387,274,1.07 [0.79-1.45],0.6541316757258769
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23327,32,1.02 [0.42-2.46],0.9705815867822032
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23526,136,0.60 [0.33-1.10],0.1000440920126484
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21682,59,1.59 [1.11-2.27],0.0116357058093291
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23537,320,0.95 [0.70-1.28],0.7273930376830979
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23086,88,1.01 [0.58-1.77],0.9700337144578766
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23030,92,1.49 [1.07-2.07],0.017178782887449
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23151,423,0.85 [0.64-1.13],0.2689905068993078
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23413,143,1.12 [0.74-1.71],0.5905812327633428
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22579,50,1.06 [0.54-2.08],0.8559050253175658
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22574,45,0.93 [0.43-2.01],0.84962890033219
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23427,56,1.72 [1.23-2.40],0.0014187949389723
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23299,147,0.81 [0.49-1.34],0.4174628524659531
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1444,28,0.75 [0.20-2.81],0.6659965878600713
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1733,54,0.97 [0.47-2.00],0.9398938892440092
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23018,80,0.60 [0.27-1.32],0.2061973197757793
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23384,894,1.03 [0.87-1.22],0.7488952298527243
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23171,642,1.08 [0.90-1.31],0.3964996649038438
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22791,262,1.14 [0.87-1.51],0.343495830784261
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23462,734,0.94 [0.77-1.15],0.57145512060199
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23524,61,1.14 [0.64-2.01],0.6632463378059654
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23398,670,0.94 [0.76-1.15],0.5368957599837314
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23498,346,0.91 [0.68-1.24],0.5573634011806653
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23454,183,0.98 [0.67-1.45],0.9329254090452012
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22567,38,1.78 [1.19-2.66],0.0046345227316872
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22570,41,0.88 [0.36-2.15],0.7741822929337833
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22589,60,0.81 [0.38-1.75],0.5995576862938627
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23460,612,0.89 [0.71-1.12],0.3365008142436114
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23001,153,0.89 [0.56-1.40],0.6111577790674644
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22780,52,1.10 [0.57-2.12],0.7673399129176448
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23234,82,0.54 [0.24-1.23],0.1406255656439037
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23425,273,1.02 [0.74-1.39],0.922334743746902
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22908,180,1.03 [0.72-1.48],0.85271599439202
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23389,118,0.74 [0.41-1.33],0.3067503383787961
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23244,396,0.94 [0.71-1.23],0.6382030685764197
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23074,136,1.25 [0.89-1.75],0.2043459605100495
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,21993,2167,1.07 [0.96-1.19],0.2121912487823634
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23393,241,0.94 [0.66-1.35],0.7483831503929799
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23514,141,0.96 [0.61-1.49],0.8470172162948268
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22861,332,1.07 [0.83-1.39],0.6028783245267182
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23205,53,0.51 [0.18-1.43],0.2009824246023573
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23512,49,1.08 [0.55-2.12],0.8336111100623111
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22607,78,0.86 [0.44-1.66],0.6497945770587719
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22657,128,0.83 [0.50-1.40],0.4909986884982007
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22583,93,0.77 [0.40-1.48],0.4393234302734424
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22781,53,0.86 [0.40-1.85],0.6913851727850918
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22545,55,0.90 [0.44-1.87],0.7834223778958871
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22949,101,0.44 [0.21-0.96],0.0384791746488395
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23002,154,0.82 [0.51-1.33],0.4260789582256717
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22638,109,1.03 [0.64-1.65],0.9092017170105512
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22571,81,0.78 [0.41-1.50],0.4590472773660397
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22549,59,0.87 [0.41-1.85],0.7156723502382503
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,21620,1794,1.06 [0.94-1.19],0.3697698449448864
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22606,77,1.24 [0.79-1.95],0.3491757448953271
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23312,374,1.18 [0.95-1.47],0.1317472553894173
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22978,40,1.19 [0.58-2.42],0.6314516263121274
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23084,146,1.21 [0.85-1.71],0.28356741622886
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23314,99,1.47 [1.06-2.03],0.0200313040370647
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23496,95,1.36 [0.96-1.94],0.0839491960467394
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23430,127,1.02 [0.67-1.57],0.9122364874888698
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23276,61,1.28 [0.77-2.11],0.3381989619523117
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23282,67,0.66 [0.29-1.52],0.3317106889872859
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23444,680,1.09 [0.91-1.31],0.3447818949049728
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23230,466,1.06 [0.85-1.33],0.602091121436129
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22865,101,0.82 [0.45-1.51],0.528602902420293
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22836,72,1.35 [0.90-2.04],0.1492915854492095
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Acute pharyngitis,23296,75,0.44 [0.18-1.08],0.0735741795806521
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23425,204,0.90 [0.62-1.32],0.5996596827990377
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23275,54,1.30 [0.81-2.09],0.283380225595746
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,All influenza,22079,110,1.46 [1.05-2.02],0.0235094562924583
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22078,109,1.46 [1.05-2.03],0.0228562748603066
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Allergic asthma (mode),16724,116,1.24 [0.86-1.79],0.245133812070864
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Allergic rhinitis,23419,245,1.07 [0.80-1.43],0.6346182782323797
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18258,1806,1.05 [0.94-1.18],0.3681175563716814
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18389,1781,1.05 [0.94-1.18],0.4073082885787646
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23187,112,1.31 [0.91-1.88],0.1468000756088935
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22027,58,1.28 [0.76-2.15],0.3578342471607736
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Bronchiectasis,20316,344,1.22 [0.97-1.53],0.0911363124748039
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20033,61,1.27 [0.76-2.11],0.3595544113861517
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22540,2568,1.08 [0.98-1.19],0.1066926754126141
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22437,57,1.06 [0.57-1.97],0.8480227877326093
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Chronic sinusitis,22503,123,1.02 [0.66-1.57],0.9321429571720729
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23386,880,1.13 [0.96-1.32],0.1545798023119159
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Deviated nasal septum,22447,67,0.76 [0.36-1.61],0.4733831927903787
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21727,4411,1.08 [1.01-1.16],0.0340580753708292
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22674,294,1.17 [0.91-1.49],0.2225078805432296
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Early onset COPD,22780,274,1.25 [1.02-1.53],0.0311798176072515
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Emphysema,20202,230,1.10 [0.79-1.54],0.5805321252051118
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22092,195,1.16 [0.83-1.61],0.3774642792558076
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23364,1395,1.19 [1.06-1.34],0.0030461172384197
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Interstitial lung disease,22126,229,1.17 [0.87-1.58],0.2957121692631882
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Later onset COPD,22739,606,1.05 [0.85-1.30],0.643646178775924
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23530,187,1.38 [1.06-1.80],0.0168663845258159
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Nasal polyp,22438,58,1.18 [0.69-2.01],0.5464559762883237
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23335,799,1.12 [0.95-1.32],0.1965792355542585
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other diseases of pleura,23372,1490,1.13 [1.01-1.28],0.0381531911066424
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23059,679,1.10 [0.93-1.31],0.2621273372600419
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other pleural conditions,21916,34,1.57 [0.99-2.48],0.0545848799562511
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23459,292,1.13 [0.86-1.48],0.3951965439708031
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23459,1013,1.13 [0.97-1.30],0.1112465769213166
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Pleural effusion,22593,711,1.13 [0.95-1.34],0.1707771331679178
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Pleural plaque,21923,41,1.24 [0.65-2.35],0.5151548159693087
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23155,1186,1.19 [1.04-1.35],0.0089445378097882
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23502,159,1.28 [0.94-1.76],0.1211896322004838
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Pneumothorax,21970,88,1.17 [0.72-1.88],0.5255857242495912
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Pollen allergy,23514,207,1.05 [0.76-1.45],0.7871796704674952
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Pulmonary oedema,23220,53,0.91 [0.41-2.03],0.8231660028060099
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Respiratory insufficiency,16649,41,1.51 [0.84-2.71],0.1704350471026358
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23317,781,1.12 [0.95-1.32],0.1870374859586746
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22625,245,1.08 [0.81-1.43],0.6161593157946728
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Viral pneumonia,22149,180,1.24 [0.91-1.69],0.1797775990487211
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23195,143,1.08 [0.71-1.63],0.7271226148716683
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11334,88,1.43 [0.99-2.08],0.0593007182425472
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16846,36,1.14 [0.54-2.40],0.7369354312874923
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Acute appendicitis,23365,120,1.43 [1.08-1.89],0.0122425425002658
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Acute gastritis,17691,69,1.43 [0.96-2.12],0.0757277075130154
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Acute pancreatitis,21566,137,0.80 [0.48-1.35],0.4097339555560215
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Acute peritonitis,23044,74,1.35 [0.88-2.05],0.1653418866661463
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22793,31,1.20 [0.57-2.51],0.6327075154316119
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Barrett oesophagus,17923,301,1.07 [0.82-1.41],0.6106093501842661
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21497,68,1.12 [0.62-1.99],0.7126445896982214
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23178,68,1.10 [0.61-1.98],0.7483097182912759
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Cholecystitis,21583,154,1.17 [0.83-1.67],0.3680095353331287
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Cholelithiasis,22455,1026,0.97 [0.83-1.14],0.7441728545581736
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Chronic gastritis,17909,287,1.09 [0.82-1.43],0.551240747960744
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21461,32,1.17 [0.56-2.44],0.6781172382013663
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23467,64,1.45 [0.94-2.22],0.0918735514374857
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Coeliac disease,22210,129,1.54 [1.22-1.94],0.0002386683998252
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Collagenous colitis,21908,92,1.10 [0.69-1.77],0.6773483410492422
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23421,135,1.04 [0.69-1.56],0.8492260290844431
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Constipation,23245,1452,1.07 [0.94-1.21],0.2885899292092373
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Crohn disease,21884,68,1.15 [0.70-1.88],0.5940510702172717
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23229,48,1.34 [0.82-2.17],0.23889923065583
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21886,70,1.12 [0.67-1.86],0.6633756920955454
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Dental caries,22821,199,1.09 [0.79-1.51],0.5877616534217062
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22130,2089,1.02 [0.92-1.14],0.6645018819931403
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of appendix,23403,158,1.37 [1.05-1.78],0.0202936876536051
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of liver,23452,690,1.05 [0.87-1.27],0.5841067762029608
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21559,3937,1.04 [0.96-1.13],0.2932675186483667
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23132,510,1.02 [0.83-1.27],0.8278581645602305
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23430,460,1.03 [0.82-1.30],0.7839871670019356
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22724,102,1.17 [0.77-1.77],0.4646614971142258
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22596,53,1.36 [0.85-2.17],0.2055733196611426
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23279,1198,1.11 [0.98-1.27],0.106410658403325
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of tongue,22599,90,0.94 [0.54-1.64],0.8351950170034644
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22802,1373,1.02 [0.89-1.17],0.7685883305429603
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19549,2739,0.97 [0.88-1.07],0.5015604598977268
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Duodenal ulcer,17737,115,1.09 [0.70-1.69],0.6957850333179124
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23487,96,1.01 [0.60-1.69],0.9781030379119048
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23450,57,0.68 [0.30-1.58],0.3741656503887602
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22843,81,1.21 [0.75-1.97],0.4298103322331592
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16909,99,0.96 [0.58-1.60],0.8833775931286167
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Functional dyspepsia,18192,570,0.98 [0.80-1.22],0.8799845560845545
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastric ulcer,17923,301,1.14 [0.88-1.48],0.3259065757339286
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19998,2376,0.98 [0.88-1.09],0.6923190560324255
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18033,411,1.15 [0.92-1.44],0.2096798725141206
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18407,7194,1.03 [0.98-1.09],0.2720335383283853
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,GI-bleeding,23033,952,0.98 [0.83-1.16],0.8095880933514367
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22684,62,1.34 [0.85-2.10],0.2095603850093701
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17652,1093,1.03 [0.89-1.18],0.7381968249059248
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22796,34,0.97 [0.38-2.50],0.956521362632112
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Hernia,22509,2468,1.02 [0.92-1.13],0.7191892039959935
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Impacted teeth,23458,52,0.70 [0.30-1.67],0.4227678937199354
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Impaction of intestines,16868,58,0.96 [0.49-1.89],0.915704967346562
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Inguinal hernia,20192,151,1.23 [0.89-1.70],0.2038995046196368
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16892,82,1.23 [0.79-1.91],0.3598906709027123
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22237,156,1.47 [1.17-1.85],0.0010917188347496
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17504,694,0.92 [0.75-1.12],0.3986009757270982
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23524,294,0.93 [0.67-1.28],0.6442436133131768
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22517,701,1.01 [0.84-1.22],0.9110836858393544
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22754,938,0.99 [0.84-1.17],0.9232374292846706
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17751,129,1.23 [0.87-1.75],0.2416156083785637
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Oesophagitis,18113,491,1.07 [0.86-1.33],0.5498287028778146
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23494,139,1.08 [0.73-1.59],0.6912278304831887
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20095,54,1.15 [0.62-2.14],0.6579759906659955
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17896,1086,0.99 [0.84-1.15],0.8476755758413439
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21683,254,0.97 [0.69-1.36],0.8644439676685447
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21593,164,0.91 [0.59-1.40],0.6526108284129584
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of intestine,18172,1362,0.95 [0.82-1.09],0.4570037948315887
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of intestines,21684,4874,0.98 [0.91-1.05],0.5602088574841568
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22596,200,1.05 [0.75-1.46],0.7757572605199529
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of liver,23334,572,1.00 [0.81-1.24],0.9922639105099852
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18134,512,1.20 [1.00-1.44],0.0547236354968423
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21567,138,1.21 [0.84-1.73],0.311948265768865
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23373,403,0.98 [0.76-1.26],0.8722999708878751
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18547,925,1.04 [0.88-1.22],0.6575617653865233
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23049,968,0.97 [0.82-1.15],0.7171634154086928
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22773,151,0.83 [0.52-1.34],0.4463048351635332
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18313,1503,1.05 [0.93-1.19],0.4286760088167139
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19405,1783,1.05 [0.94-1.18],0.3830466410346642
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22851,89,1.32 [0.90-1.94],0.1616345039578118
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22645,829,1.02 [0.86-1.21],0.7913305728217684
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17099,289,1.07 [0.81-1.41],0.6451522109561758
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23441,66,0.60 [0.26-1.38],0.2255081130063914
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17238,428,1.09 [0.87-1.36],0.4441286394919689
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22198,117,1.42 [1.06-1.92],0.020285676952721
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23529,65,0.61 [0.25-1.44],0.2575633255364239
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22624,116,0.76 [0.43-1.34],0.3408433041908296
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Toxic colitis,21870,54,1.05 [0.53-2.06],0.8955907024196472
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17832,210,1.16 [0.85-1.58],0.3413210529044722
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Ulcerative colitis,21961,145,0.71 [0.42-1.21],0.2035588092159864
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21938,122,0.76 [0.44-1.33],0.3363340111544293
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Umbilical hernia,20191,150,0.85 [0.52-1.39],0.5129765676073209
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16975,165,0.80 [0.50-1.28],0.3583036541822105
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Ventral hernia,20253,212,1.13 [0.82-1.55],0.4564052222665345
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Volvulus,16884,74,0.98 [0.55-1.76],0.957568368770192
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23463,210,1.30 [1.01-1.67],0.0392637735503227
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23258,73,1.30 [0.86-1.97],0.21599398714958
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21789,194,1.09 [0.79-1.50],0.6010284273966375
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23072,540,1.08 [0.88-1.34],0.4543744648735623
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22659,127,1.19 [0.81-1.74],0.3703478852292625
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21861,266,1.36 [1.08-1.71],0.0095364247000113
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23267,241,1.13 [0.85-1.51],0.4062730447870161
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23435,409,1.20 [0.98-1.48],0.0744824324417656
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23066,40,0.97 [0.43-2.19],0.9424280860860618
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22160,2700,1.07 [0.98-1.17],0.1298546876402503
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23145,399,1.02 [0.80-1.30],0.8778932904612922
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23018,272,1.06 [0.80-1.40],0.709162944640259
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23255,723,1.06 [0.89-1.28],0.5103616741523009
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23517,67,0.91 [0.47-1.75],0.7683024252916975
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21680,85,1.35 [0.91-1.99],0.1307535772581123
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22784,38,1.15 [0.57-2.32],0.7017522281297904
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23254,228,0.95 [0.67-1.35],0.7899541200374558
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21958,363,0.86 [0.64-1.16],0.3262024284599911
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21639,44,1.25 [0.69-2.27],0.4575411636034947
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23446,67,1.11 [0.63-1.97],0.7164443389346172
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22659,127,0.98 [0.61-1.57],0.9411040021065772
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23333,148,1.21 [0.86-1.69],0.2770448542632194
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23068,42,0.99 [0.41-2.35],0.9734822360381636
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21652,57,0.92 [0.45-1.89],0.829632401083036
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22960,1365,1.06 [0.93-1.21],0.367053875664604
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21986,391,0.86 [0.64-1.14],0.2922880798154058
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21643,48,1.19 [0.65-2.19],0.5785431955030256
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23462,277,1.24 [0.98-1.56],0.0764239890721102
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23096,70,1.49 [1.04-2.13],0.030630175273124
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23398,213,1.30 [1.01-1.66],0.0410260047750604
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23489,236,1.32 [1.05-1.66],0.016639042410468
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21737,142,1.07 [0.73-1.56],0.7268755381057663
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21824,229,0.77 [0.51-1.15],0.2030007559633966
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23478,225,1.35 [1.07-1.69],0.0097943670344427
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21766,171,1.20 [0.85-1.70],0.3099353304557638
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23504,125,0.94 [0.58-1.53],0.8092895796365775
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20079,116,0.92 [0.56-1.50],0.7281769510412555
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21371,5487,0.98 [0.91-1.05],0.5216712098521175
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20184,4300,1.03 [0.96-1.11],0.396200426771657
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20030,67,0.73 [0.34-1.58],0.4237264456994234
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20198,131,0.96 [0.61-1.51],0.854125465378841
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20248,181,0.99 [0.68-1.44],0.9482569305141388
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23291,98,1.16 [0.76-1.78],0.4924021649335326
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20166,99,0.69 [0.35-1.36],0.2869198967864937
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17078,1194,1.06 [0.92-1.21],0.4093777758999972
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23400,199,1.01 [0.70-1.45],0.9742148984081276
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20569,502,1.01 [0.80-1.27],0.9504761928871668
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19773,6987,1.02 [0.96-1.09],0.4382666891431973
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21070,114,0.89 [0.53-1.51],0.6682638548473108
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20079,116,0.79 [0.44-1.41],0.4298288249027944
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20556,593,0.97 [0.79-1.20],0.7911964301700893
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22657,2590,0.95 [0.86-1.06],0.3467395362546422
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20116,153,0.94 [0.62-1.44],0.7887938584928817
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20300,337,1.12 [0.88-1.42],0.3598139780701325
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20115,152,0.90 [0.58-1.39],0.6225286772765726
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22682,94,0.63 [0.31-1.28],0.2015963159783709
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17506,1622,1.07 [0.95-1.21],0.2406393513654052
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16060,176,1.29 [0.95-1.75],0.102984695056715
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23523,173,1.30 [0.94-1.80],0.1148014103727693
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,15975,91,0.97 [0.58-1.62],0.9112880434179648
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16380,496,1.04 [0.84-1.27],0.7338712111560668
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20250,287,0.95 [0.70-1.30],0.7661374005690192
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16438,554,1.01 [0.82-1.24],0.9504834268941008
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20124,57,1.04 [0.54-2.02],0.8960542247279625
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20685,618,1.00 [0.81-1.23],0.9861779160671486
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20354,287,0.86 [0.62-1.21],0.3927864917304634
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16399,515,0.98 [0.79-1.23],0.8835221969416758
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20037,74,0.83 [0.42-1.64],0.5930333530404905
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20022,59,1.20 [0.71-2.03],0.5055273633048206
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,21000,44,0.69 [0.25-1.89],0.468979696046397
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23132,2176,1.07 [0.97-1.19],0.1759029916818578
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22523,1567,1.07 [0.95-1.20],0.2824803085321788
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23358,506,1.09 [0.88-1.34],0.4273324697212823
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18504,2620,1.05 [0.95-1.15],0.3376427451177268
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,15945,61,1.04 [0.58-1.86],0.899851229308156
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20053,90,1.21 [0.79-1.86],0.3788769840978594
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,15926,42,0.81 [0.31-2.11],0.6625359405446613
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16061,177,0.87 [0.57-1.32],0.5109357002754109
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21211,255,1.05 [0.78-1.42],0.7602389477269104
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21453,497,1.08 [0.88-1.33],0.4603387116077542
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23512,93,1.59 [1.20-2.10],0.0012715098561209
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21820,1753,0.97 [0.86-1.10],0.6435463595744004
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20075,112,1.35 [0.98-1.85],0.0622491861015796
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16088,204,0.69 [0.44-1.09],0.1147879593828502
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20761,694,0.87 [0.70-1.09],0.2229559039736421
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18090,2206,0.99 [0.89-1.10],0.8749274502113107
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22703,115,0.89 [0.52-1.50],0.6582353431662409
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23519,73,1.29 [0.85-1.96],0.2393470163947998
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20028,65,0.91 [0.45-1.81],0.7777072620445141
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21238,1275,1.17 [1.04-1.32],0.0096693319118454
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20031,68,0.99 [0.53-1.86],0.9761471971357996
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,17599,1715,0.96 [0.84-1.09],0.5193624000074666
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21082,126,0.85 [0.51-1.42],0.5341551883498746
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20013,50,1.32 [0.82-2.12],0.2474568203705333
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20235,168,1.02 [0.69-1.51],0.924972913417302
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20461,498,1.28 [1.07-1.52],0.00557009940116
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23031,443,1.24 [1.02-1.51],0.0285790983525486
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20618,551,0.95 [0.76-1.20],0.6823483212416488
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23370,489,1.09 [0.88-1.35],0.4313532305695675
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23512,58,0.38 [0.13-1.12],0.0795815858387102
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20159,196,0.97 [0.67-1.40],0.8757424383537318
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18041,796,0.90 [0.74-1.11],0.3267668346558766
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20538,575,1.06 [0.87-1.30],0.5504381393193472
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20069,106,1.16 [0.77-1.74],0.4884081473255273
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",15955,71,0.82 [0.40-1.68],0.5840926661918624
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18157,2273,0.96 [0.86-1.07],0.4371506125791602
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16614,730,0.95 [0.77-1.15],0.5786876449663919
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22845,257,1.09 [0.81-1.48],0.557630861321973
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23488,69,1.66 [1.22-2.25],0.0012885787497195
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21557,47,0.96 [0.42-2.17],0.9190781373034156
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,15958,74,1.26 [0.83-1.90],0.2725285320596011
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20166,99,0.99 [0.59-1.66],0.9761076506064252
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16394,510,1.06 [0.86-1.31],0.5811290185313083
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20240,277,1.04 [0.78-1.39],0.785647058429283
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20318,251,1.28 [1.01-1.62],0.0412123884990333
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20304,237,0.90 [0.63-1.30],0.5890138340654599
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18139,74,1.02 [0.57-1.81],0.9501471589792924
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23518,64,0.41 [0.15-1.13],0.0864300180019427
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20510,547,1.05 [0.86-1.29],0.6387900225443822
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],22732,144,1.37 [1.02-1.83],0.03489424148035
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22388,2425,1.09 [1.00-1.20],0.0586285828913549
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20099,136,1.19 [0.83-1.69],0.3469688990469839
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20553,486,1.20 [0.99-1.46],0.0564711972319572
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22024,216,1.02 [0.72-1.44],0.912821356452694
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20282,215,1.15 [0.85-1.56],0.3589070757838731
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21552,1485,1.05 [0.93-1.20],0.4246094343558497
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21080,1013,1.03 [0.88-1.21],0.681966707011184
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20020,57,1.32 [0.81-2.15],0.2690641883496271
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22794,206,1.46 [1.18-1.81],0.0005299795183767
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20131,168,0.90 [0.59-1.37],0.6293072559189806
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20078,115,1.26 [0.87-1.80],0.2195067414246075
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),15929,45,1.42 [0.89-2.28],0.1407967830447153
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22709,1024,1.30 [1.14-1.47],6.154007747134059e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17598,87,0.93 [0.53-1.63],0.7876179644260949
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,22937,100,0.86 [0.49-1.51],0.6030408732691378
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23406,195,1.08 [0.77-1.51],0.653325278074525
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23232,21,0.66 [0.15-2.93],0.5823469205057719
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22830,1145,1.16 [1.02-1.33],0.0277138105339538
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23398,57,1.81 [1.31-2.48],0.0002696923082412
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23366,196,1.07 [0.75-1.52],0.7108956074869306
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Cystitis,20798,211,1.18 [0.88-1.58],0.2682547108242823
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Dialysis,21729,44,1.47 [0.89-2.42],0.1319089288703422
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23121,284,1.19 [0.93-1.51],0.1587961209978364
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Endometriosis,17659,148,1.09 [0.76-1.56],0.6530444228085523
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",17844,333,1.00 [0.77-1.29],0.9887907672440728
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18371,860,0.99 [0.83-1.18],0.9242946919623162
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18290,4260,1.05 [0.97-1.13],0.1948541550406092
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23393,52,1.25 [0.71-2.19],0.4484746551774519
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,21565,174,1.16 [0.84-1.61],0.3701526910029445
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23064,340,0.93 [0.69-1.24],0.6117360113609687
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Irregular menses,23128,106,1.18 [0.82-1.71],0.3789255909888319
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Menorrhagia,17773,262,0.88 [0.63-1.23],0.4433042250449376
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20653,66,0.57 [0.23-1.39],0.215106256877555
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19604,2093,0.98 [0.87-1.09],0.6826786411315842
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17627,116,0.82 [0.48-1.42],0.4809871335287854
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23527,55,0.95 [0.47-1.92],0.8863547191034973
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23527,68,1.35 [0.87-2.09],0.1796492691025929
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22472,1885,1.08 [0.97-1.20],0.1711350332552685
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20992,405,1.07 [0.84-1.35],0.5974983535874397
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,22937,100,1.55 [1.19-2.01],0.0009834508988367
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23487,317,1.09 [0.83-1.43],0.5242449476446465
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23485,76,0.78 [0.39-1.57],0.4811542878357504
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22198,1611,1.09 [0.97-1.23],0.1421070794952258
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,22899,175,0.89 [0.59-1.35],0.5890835740405871
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17645,134,0.97 [0.62-1.52],0.9045226334385884
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17843,332,1.01 [0.77-1.33],0.926751283406568
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17612,101,1.07 [0.68-1.69],0.7667842447195417
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17688,177,0.73 [0.45-1.19],0.2015320102367307
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21609,218,1.14 [0.85-1.54],0.3795526746782492
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23275,105,1.07 [0.67-1.72],0.7689066741657468
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17771,260,1.06 [0.80-1.41],0.6818180789998551
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17603,92,0.81 [0.44-1.49],0.494310317936009
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18059,548,1.18 [0.99-1.40],0.0634446070473933
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17650,139,1.11 [0.76-1.63],0.5885152911837502
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18014,503,1.10 [0.90-1.34],0.353337613844752
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23374,33,1.36 [0.73-2.53],0.3269598834820849
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23390,1999,1.17 [1.06-1.29],0.0021632285526116
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",21533,142,1.17 [0.82-1.66],0.390535454288877
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21767,82,1.12 [0.67-1.88],0.6669627909489402
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23241,30,1.44 [0.83-2.48],0.1911358066771917
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20710,123,0.86 [0.51-1.45],0.5767120159720447
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23434,223,1.09 [0.80-1.48],0.594023138113746
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17632,121,0.86 [0.51-1.45],0.5763957914080837
